Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has completed enrollment in the pivotal cohort (Cohort 1) of the global Phase 3 REVEAL study evaluating obudanersen (ION582), an ...

Microsoft’s latest layoffs coincide with rising H‑1B filings, intensifying scrutiny of its AI‑driven workforce shift.

Vanta reports four risk treatment strategies—mitigate, accept, transfer, and avoid—to effectively manage threats, enhancing ...

A detailed look at the Eagles’ quarterback room entering 2026 training camp, led by Jalen Hurts, Andy Dalton, Tanner McKee ...

The study tested 267 soldiers, finding that 20 minutes of activity strongly predicts performance on the Armed Forces ...

CEOs faced a week of pivotal decisions, from succession planning to rebuilding trust. Learn from JPMorgan, BP, Nike, ...

Alternative to Meds Center has expanded its educational resources on Caplyta side effects. Whenever a newer medication ...

Goldcattle How do global procurement managers consistently source precision components that meet strict geometric tolera ...

Dr. John Spencer Ellis has launched Rep Radar, a free platform from Reputation Return that delivers comprehensive ...

Interactive Booklet Series Translates Muzha's Natural Landscape Into Layered Visual Storytelling Honored by A' Design ...

WHO’s adaptive Ebola trial in Congo tests MBP134 and remdesivir vs supportive care for Bundibugyo strain, tracking 28-day mortality—read the update now.

Sacramento, California - July 06, 2026 - PRESSADVANTAGE - Silverback Digital Marketing has announced an overview of its ...